Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Manetsch, M. M. Rahman, B. Patel, E. Ramsay, N. Rumzhum, H. Alkhouri, Q. Ge, A. Ammit (Sydney, Australia). Long-acting beta₂-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells. Eur Respir J 2013; 42: Suppl. 57, 563

Member's Comments

No comment yet.

Related content which might interest you: Corticosteroid insensitivity and enhanced mitogen-activated protein kinase activity in airway smooth muscle cells of severe asthma Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011 Role of protein phosphatase 5 (PP5) in mediating corticosteroid insensitivity in airway smooth muscle (ASM) cells in severe asthma Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 The long-acting β2-agonist formoterol re-establishes the anti-proliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC) Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011 Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli Source: Eur Respir J 2006 Oct 01;28(4):703-711 Year: 2006 Formoterol reduces asthmatic airway smooth muscle cell proliferation through p27 (Kip) which is supported by steroids Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 The c-jun N-terminal kinase signaling pathway regulates airway smooth muscle cell proliferation Source: International Congress 2014 – Cell biology 2014 Year: 2014 A comparison of beta2-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013 Mevastatin ameliorates sphingosine 1-phosphate-induced inflammation in human tracheal smooth muscle cells Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta2-adrenoceptor agonists in airway smooth muscle Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 MAP kinase phosphatase 1 mediates glucocorticoid inhibition of CD38 expression in human airway smooth muscle Source: Annual Congress 2008 - Basic science in asthma and COPD II Year: 2008 Compound A (CpdA) suppressed production of corticosteroid-resistant chemokines via GR-independent mechanisms in airway smooth muscle (ASM) cells Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016 Budesonide and formoterol differentially modulate the expression of C/EBP-alpha and calreticulin in airway smooth muscle (ASM) cells Source: Eur Respir J 2006; 28: Suppl. 50, 756s Year: 2006 Impaired inhibitory action of corticosteroids on chemokine expression induced by TNFalpha in airway smooth muscle (ASM) cells from patients with severe asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Epac1 and Epac2 regulate airway smooth muscle tone in mice Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Compound A modulates steroid insensitive chemokines in airway smooth muscle cells via IRF-1 dependent and independent pathways Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015